StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3076% below fair value
$2.38−0.23 (-8.64%)

Close on Nov 20, 2026Market cap $23.68MP/E –Yield –

Scynexis gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2014 it was $3.58M, up 548.2% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2014Dec 31, 2014$3.58M+548.2%
FY2013Dec 31, 2013$552.00K–

More Scynexis figures

See a number that looks wrong?